CD19 car circRNA-LNP

Product Specifications

UNSPSC Description

CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car circRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction[1][2].

Target Antigen

CD19; Liposome

Type

Biochemical Assay Reagents

Related Pathways

Immunology/Inflammation;Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/cd19-car-circrna-lnp.html

Solubility

10 mM in DMSO

Smiles

[CD19carcircRNA-LNP]

References & Citations

[1]Xu Y, et al. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. Blood. 2014 Jun 12;123(24):3750-9. |[2]Li X, et al. CD19, from bench to bedside. Immunol Lett. 2017 Mar;183:86-95.